glp-1 treatment baton rouge GLP-1 medications are changing the landscape of weight management. But GLP-1 Agonists: A Comprehensive Overview

While the mechanism is not fully understood, BPC-157 appears to influence dopamine and serotonin systems in ways that may counteract some of the mood changes that occasionally accompany significant dietary restriction

GLP-1 agonists also stimulate pancreatic beta cells to secrete insulin and tamp down glucagon secretion from the pancreatic alpha cells

Decisions about your dose or your treatment belong with the clinician who prescribed it

The current crop of obesity drugs (incretin analogs and combinations with muscle sparing mAbs) will remain pricey and inaccessible to many in need, and come with side effects that limit adherence

1993;101(1 Suppl):143S-147S

Dodd, D